Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
Updated 2026-06-05
Twist Bioscience Corp (TWST) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $2.27M | $-44.09M | -315.20% | -1,924.02% | -1,943.06% |
| 2017 | $10.77M | $-59.31M | -123.09% | -543.16% | -550.85% |
| 2018 | $25.43M | $-71.24M | -26.59% | -277.50% | -280.16% |
| 2019 | $54.38M | $-107.67M | 12.80% | -200.15% | -197.98% |
| 2020 | $90.10M | $-139.93M | 31.85% | -155.47% | -155.31% |
| 2021 | $132.33M | $-152.10M | 39.08% | -115.41% | -114.94% |
| 2022 | $203.56M | $-217.86M | 41.38% | -122.33% | -107.02% |
| 2023 | $245.11M | $-204.62M | 36.61% | -88.60% | -83.48% |
| 2024 | $312.97M | $-208.73M | 42.61% | -70.56% | -66.69% |
| 2025 | $376.57M | $-77.67M | 50.72% | -36.18% | -20.63% |
Frequently asked questions
What is Twist Bioscience Corp's revenue?
Twist Bioscience Corp's trailing twelve-month revenue is $409.48M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is TWST?
In its most recent fiscal year, TWST ran a gross margin of 50.72%, an operating margin of -36.18%, and a net margin of -20.63%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does TWST generate?
TWST produced $-75.63M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is TWST's balance sheet healthy?
TWST holds $183.05M in cash and equivalents against — in long-term debt, on $472.96M of shareholder equity. That debt is best read against the cash flow the business throws off each year.